As a scientist on Illumina’s Assay Research team in San Diego, Suzanne Rohrback works with colleagues to come up with new ways next-generation sequencing (NGS) can maximize insights from a sample—such as cells from a tumor or a tube of blood—extracting as much information about it as possible, as efficiently as possible.